The Journal of Immunology, Vol 152, Issue 10 4929-4936, Copyright © 1994 by American Association of Immunologists

ARTICLES

Molecular cloning and expression of early T cell costimulatory molecule- 1 and its characterization as B7-2 molecule

C Chen, A Gault, L Shen and N Nabavi
Department of Inflammation and Autoimmune Diseases, Roche Research Center, Nutley, NJ 07110.

The interaction of T cell CD28/CTLA-4 receptors with B7-1 activation Ag on APC represents an important costimulatory pathway in T cell activation. However, it is now evident that this costimulatory pathway is neither unique nor universal for the activation of T cells. Our previous study indicated that a 60-kDa membrane protein, recognized by mAb 2D10, was expressed before B7 by activated murine B cells. This molecule was critically involved in activation of T cells in response to auto- and alloantigens. In the present study, we report on the isolation of a cDNA for this early T cell costimulatory molecule (ETC- 1). ETC-1, like B7-1, is a member of the Ig supergene family and is composed of 303 amino acids. Nucleic acid sequence comparison indicated that ETC-1 is identical to the B7-2 molecule. When expressed in Chinese hamster ovary cells, ETC-1 showed profound T cell costimulatory activity as demonstrated by its ability to enhance CD4 T cell proliferation in response to Con A or anti-CD3 stimulation. Furthermore, ETC-1 also bound to both CD28-Ig and CTLA4-Ig fusion proteins. These results strongly support the notion that the interaction of ETC-1/B7-2 with CD28 or CTLA-4 receptors represents an alternative T cell costimulatory pathway.

This article has been cited by other articles:

				D. J. Kasprowicz, A. P. Kohm, M. T. Berton, A. J. Chruscinski, A. Sharpe, and V. M. Sanders Stimulation of the B Cell Receptor, CD86 (B7-2), and the {beta}2-Adrenergic Receptor Intrinsically Modulates the Level of IgG1 and IgE Produced per B Cell J. Immunol., July 15, 2000; 165(2): 680 - 690. [Abstract] [Full Text] [PDF]

				S. Shinde, R. Gee, S. Santulli-Marotto, L. K. Bockenstedt, S. H. Clarke, and M. J. Mamula T Cell Autoimmunity in Ig Transgenic Mice J. Immunol., June 15, 1999; 162(12): 7519 - 7524. [Abstract] [Full Text] [PDF]

				L. Leifeld, C. Trautwein, F. L. Dumoulin, M. P. Manns, T. Sauerbruch, and U. Spengler Enhanced Expression of CD80 (B7-1), CD86 (B7-2), and CD40 and Their Ligands CD28 and CD154 in Fulminant Hepatic Failure Am. J. Pathol., June 1, 1999; 154(6): 1711 - 1720. [Abstract] [Full Text] [PDF]

				L. Lai, N. Alaverdi, L. Maltais, and H. C. Morse III Mouse Cell Surface Antigens: Nomenclature and Immunophenotyping J. Immunol., April 15, 1998; 160(8): 3861 - 3868. [Abstract] [Full Text] [PDF]

				D. R. Milich, M. Chen, F. Schodel, D. L. Peterson, J. E. Jones, and J. L. Hughes Role of B cells in antigen presentation of the hepatitis B core PNAS, December 23, 1997; 94(26): 14648 - 14653. [Abstract] [Full Text] [PDF]